SPOTLIGHT -
Exhibit guide
Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101
Podcast: Talking about the anterior segment pipeline for 2023
Jumping into gene therapy with collaboration, innovation
The importance of ocular health prior to cataract and refractive surgery
Unity Biotechnology announces results from Part A of the Phase 2 ENVISION study of UBX1325
Ocugen announces FDA approval for enrollment of pediatric patients in ongoing OCU400 Phase 1/2 clinical trial
